Category: Antibody Technologies
Asia Antibody Technologies
-
Research Antibodies Market, by Product Type (Primary Antibodies, Secondary Antibodies, Reagents, Consumables), by Form (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Mouse, Rabbit, Goat, Others (Guinea Pigs, Rat, etc.)), by Application (Western Blotting, ELISA, Flow Cytometry, Immunocytochemistry (ICC)/ Immunofluorescence (IF), Immunohistochemistry (IHC), Others), by End User (Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Flow Cytometry, Immunocytochemistry (ICC)/ Immunofluorescence (IF), Immunohistochemistry (IHC), Others), by End User (Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, ... Read More
-
Cytokine Market, By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF, and Other Cytokine Types), By Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cytokines are a category of small proteins important in cell signaling. They are small proteins that ... Read More
-
Single Use System in Biopharma Manufacturing Market, By Bioreactors (Less than 1000L, 1000-2000L, and More than 2000L), By Application (Filtration, Storage (Buffer & Media Storage, Freeze & Thaw), Cell Culture, Mixing, Purification, and Aseptic Filling), By Bioprocessing (Small-scale, Mid-scale, and Large-scale), By Product (Sampling Systems, Bioprocess Containers, Bioreactors, Mixers, Membrane Absorbers, Bottles, Equipment, Transfer Units, and Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps etc.)), By Modality (Protein & Monoclonal Antibody (Mab), Cell Therapy, Gene Therapy, Conventional Vaccine, and mRNA), By Component (Drug Substance and Drug Product), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... By Bioprocessing (Small-scale, Mid-scale, and Large-scale), By Product (Sampling Systems, Bioprocess Containers, Bioreactors, Mixers, Membrane Absorbers, Bottles, Equipment, Transfer Units, and Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps etc.)), By Modality (Protein & Monoclonal ... Read More
-
IVD Raw Materials Market, By Product (Antibodies & Antigens, Enzymes, Proteins, Biological Buffers, and Others), By Technology (Clinical Chemistry, Immunochemistry, Molecular diagnostics, and Others), By End-User (Pharma, Biotech & MedTech Companies, Diagnostic Laboratories, and Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 In vitro diagnostics can detect diseases/conditions, and can be used to monitor ... Read More
-
Immunotherapy Drugs Market, By Product (Monoclonal Antibodies, Immuno Modulators, Car T-Cell Therapy, Others), By Applications (Cancer, Autoimmune & Inflammatory Diseases, Others), and By Geography (Europe, APAC, North America, Latin America, And Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. Immunotherapy is preferable than the old technique as it helps treat a ... Read More
-
Oncology Drugs Market, by Drug Type (Cytotoxic Drugs (Alkylating Agents, Antimetabolites, and Others), Targeted Drugs (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), and Hormonal Drugs (Ovarian Function Blockers, Estrogen Production Blockers, and Estrogen’s Effect Blockers (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and ... Read More
-
Asia-pacific Immunoglobulin Market 2022-2028
... & New Zealand, ASEAN Countries, China, South Korea, and Rest of Asia-Pacific are studied in the market in this region. A growing demand for immunoglobulin can be observed in China with the expansion of plasma ... Read More
-
South Korea Immunoglobulin Market Forecast 2022-2028
... 2021, the forecast period is from 2022 to 2028. The main factors promoting the market growth of the country are the prevalence of different diseases and disorders due to weak immune systems as well as ... Read More
-
Asia-pacific Immunoglobulin Market Forecast 2022-2030
... fuelled by the launch of advanced and innovative immunoglobulin products, the rise in the geriatric population, and the increasing incidence of various disease types. MARKET INSIGHTS The Asia-Pacific immunoglobulin market growth assessment entails the evaluation ... Read More
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
... for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services ... Read More
-
India Immuno-Oncology Drugs Market, by Drug Type (Immune Checkpoint Inhibitors (Nivolumab, Atezolimumab, Pembrolizumab, Durvalumab), Monoclonal Antibodies (Rituximab, Trastazumab, Bevacizumab , Nimotuzumab, Pertuzumab, Ado-Trastuzumab Emtansine ), and Can
... Blood Cancer, Breast Cancer, Ovarian Cancer, Cervical Cancer, Colorectal Cancer, Stomach Cancer, Head & Neck Cancer, and Others), and by Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) - Size, Share, Outlook, and Opportunity ... Read More
-
Asia Pacific Generic Oncology Sterile Injectable Market, by Drug Type (Monoclonal Antibodies, Chemotherapy (Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, and Others), Cytokines, and Peptide Hormones), by Disease Indication (O
... Pancreatic Cancer, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Country (China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, ... Read More
-
Polyclonal Antibody Market, by Type (Primary Antibody and Secondary Antibody), by Application (Academic Research and Commercial), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Oppor
... Opportunity Analysis, 2022 - 2028 Antibodies are the type of globular proteins produced by the plasma cells. Polyclonal antibodies are produced by different types of plasma B cells and bind to different epitopes in the ... Read More
-
China Ulcerative Colitis Market, by Drug Therapy (5-Aminosalicylates {Mesalazine, Balsalazide, Olsalazine, and Others}, Monoclonal Antibodies {Vedolizumab, Adalimumab, Infliximab, Golimumab, and Ustekinumab}, Steroids {Budesonide, Prednisone, Beclomethaso
... and Others}, and Other Drugs), by Dosage Form (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Ulcerative colitis is the ... Read More
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
Asia Pacific Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Asia Pacific monoclonal antibodies market is expected to reach US$ 44,729.7 million by 2028 from US$ 18,344.5 ... Read More
-
Global and Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Insights, Forecast to 2028
... NK-Cell Engaging Bispecific Antibodies market. In 2021, the global T-Cell & NK-Cell Engaging Bispecific Antibodies market size was US$ 472 million and it is expected to reach US$ 5072 million by the end of 2028, ... Read More
-
Asia Pacific Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... proteins, and Biosimilar antibody products) The Asia Pacific (APAC) next-generation antibody market is expected to reach US$ 2,312.68 million by 2028 from US$ 999.49 million in 2021. It is estimated to grow at a CAGR ... Read More
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The Philippines, Malaysia, Singapore, Thailand, Vietnam, Rest of South East Asia, Taiwan, Hong Kong, Macau, Japan, South Korea, India, Australia, China, and Rest of Asia Pacific)) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
Antibody Cocktails Market, by Type (Monovalent Antibody and Polyvalent Antibody), by Indication (COVID-19, Cancer, HIV, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 An antibody, also called immunoglobulin, is a protective protein produced by the immune system of the body in response ... Read More
-
Chronic Liver Diseases Therapeutics Market, by Treatment Type (Antiviral Drugs, Immunosuppressant’s, Vaccines, Immunoglobulin’s, Corticosteroids, Targeted Therapy, and Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The liver ... Read More
-
Middle East and Asia Pacific Biotechnology Market, by Technology (Nanobiotechnology, Tissue Engineering and Regeneration, Fermentation, Cell Based Assay, CRISPR, and Others ), by Application (Molecular Biology, Gene Synthesis, Gene Editing, Mammalian Protein Expression, Recombinant Antibody Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) ... Read More
-
Plasma Derived Medicine Market, by Product Type (Albumin, Coagulation factors, Immunoglobulins, and Others), by Indication (Pelvic Inflammatory Disease (PID), Bleeding Disorders, Alpha-1 Antitrypsin Deficiency (AATD), Hereditary Angioedema (HAE), Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Multifocal Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
-
Blood Grouping Reagents Market Research Report: Information by Product (Consumables and Instruments), by Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), by Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2027
... Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2027 Blood Grouping Reagents Market ... Read More
Research Assistance
